Skip to main content
Elsevier

Hepatic Encephalopathy, An Issue of Clinics in Liver Disease

  • 1st Edition, Volume 24-2 - April 15, 2020
  • Latest edition
  • Author: Vinod K. Rustgi
  • Language: English

In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Vinod Rustgi has put together topics that provide a current clinical update on the treatment and management of… Read more

Purchase options

Info / Buy

Description

In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Vinod Rustgi has put together topics that provide a current clinical update on the treatment and management of patients with Hepatic Encephalopathy (HE). Experts in the field have contributetd clinical review articles on the following topics: Definition, Prevalence, and Epidemiology of HE; Pathophysiology of HE; Clinical Manifestations of HE; Laboratory Abnormalities of HE; Minimal or Subclinical HE; Prognosis of Prognosis of HE; Pharmacological Management of HE; Non-pharmacological Management of HE; Cost Burden of HE; Long-term management of HE: Modern Measures to Prevent Re-admission; Social Impact of HE; and Novel Therapies for HE. Readers will come away with the information they need to improve outcomes in patients with HE.

Table of contents

Alagille Syndrome

Alpha-1-Antitrypsin Deficiency Liver Disease

Progressive Familial Intrahepatic Cholestasis

Inborn Errors of Bile Acid Metabolism

Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing

Cholangitis or Overlap Syndrome

Hepatitis B and C

Nonalcoholic Liver Disease in Children and Adolescents

Cirrhosis and Portal Hypertension in the Pediatric Population.

Pediatric Liver Tumors

Acute Liver Failure: An Update

Liver Transplantation in Children

Product details

  • Edition: 1
  • Latest edition
  • Volume: 24-2
  • Published: May 11, 2020
  • Language: English

About the author

VR

Vinod K. Rustgi

Dr. Vinod Rustgi is a Professor in Epidemiology in the School of Public Health and a Professor in Pathology and Lab Medicine. He previously served as Program Director for the Gastroenterology Fellowship until the 2022/2023 academic year and currently serves as Associate Program Director. He has extensive experience in hepatology spanning over 30 years and previously held the position of Medical Director of Liver Transplantation at the University of Pittsburgh’s Starzl Transplant Institute. His research and clinical interests include outcomes research in nonalcoholic steatohepatitis (NASH), other liver diseases, and cost-effectiveness modeling. He has contributed to antiviral research associated with hepatitis C cure efforts and has served on the Governing Board of the American Association for the Study of Liver Diseases (AASLD).
Affiliations and expertise
Distinguished Professor, Associate Program Director, Clinical Director of Hepatology, and Director, Center for Liver Diseases, Robert Wood Johnson Medical School (RWJMS), Rutgers Health, New Brunswick, NJ, USA